Karen Quillen, MD

Professor, Pathology & Laboratory Medicine

Karen Quillen
617.358.2694
670 Albany St .

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Queen's University, MD
  • Harvard University, AB

Publications

  • Published on 3/1/2021

    Kaufman AR, Quillen K, Distefano AG, Sloan JM. Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma. J Neuroophthalmol. 2021 Mar 01; 41(1):e77-e78. PMID: 32235225.

    Read at: PubMed
  • Published on 9/8/2020

    Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, Kataria Y, Sarosiek SR, Lerner A, Sloan JM, Quillen K, Burks EJ. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis. Am J Clin Pathol. 2020 09 08; 154(4):466-474. PMID: 32681166.

    Read at: PubMed
  • Published on 9/1/2020

    Sarosiek S, Zheng L, Sloan JM, Quillen K, Brauneis D, Sanchorawala V. Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood Cancer J. 2020 09 01; 10(8):88. PMID: 32873776.

    Read at: PubMed
  • Published on 10/4/2019

    Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319. PMID: 31489689.

    Read at: PubMed
  • Published on 5/9/2019

    Singh P, Chen H, Gordon CE, Ghai S, Sloan JM, Quillen K, Moradi S, Chitalia V, Gautam A, Henderson J, Francis JM. Monoclonal IgG4/2? Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation. Kidney Med. 2019 May-Jun; 1(3):139-143. PMID: 32734194.

    Read at: PubMed
  • Published on 1/21/2019

    Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309. PMID: 30664726.

    Read at: PubMed
  • Published on 1/11/2019

    Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 05; 25(5):e169-e173. PMID: 30639823.

    Read at: PubMed
  • Published on 12/22/2018

    Quillen K. Teach, listen, love: a personalised approach to supervising doctors in training. Postgrad Med J. 2018 12; 94(1118):730. PMID: 30580323.

    Read at: PubMed
  • Published on 11/7/2018

    Shi W, Al-Sabti R, Burke PA, Gonzalez M, Mantilla-Rey N, Quillen K. Quality Management of massive transfusion protocol incorporating tranexamic acid adherence. Transfus Apher Sci. 2018 Dec; 57(6):785-789. PMID: 30455154.

    Read at: PubMed
  • Published on 6/20/2018

    Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827. PMID: 29933072.

    Read at: PubMed

View 71 more publications: View full profile at BUMC

View all profiles